Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density

Proteomics

Volumn 8, Issue 20, 2008, Pages 4259-4272

  Deng, Fei Yan ^a,b   Liu, Yao Zhong ^b   Li, Li Ming ^a   Jiang, Chen ^a   Wu, Shan ^a   Chen, Yuan ^a   Jiang, Hui ^a   Yang, Fang ^a   Xiong, Ji Xian ^a   Xiao, Peng ^c   Xiao, Su Mei ^a   Tan, Li Jun ^a   Sun, Xiao ^a   Zhu, Xue Zhen ^a   Liu, Man Yuan ^a   Lei, Shu Feng ^a   Chen, Xiang Ding ^a   Xie, Jing Yun ^a   Xiao, Gary G ^a,c   Liang, Song Ping ^a   Deng, Hong Wen ^a,b   more..

^a HUNAN NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone mineral density; Circulating monocyte; Osteoclastogenesis; Protein

Indexed keywords

GELSOLIN; GLUTATHIONE PEROXIDASE 1; MANGANESE SUPEROXIDE DISMUTASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN; RAS PROTEIN;

ADULT; ARTICLE; BETA CHAIN; BONE DENSITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FUNCTION; CHINESE; COMPARATIVE STUDY; ENDOTHELIUM; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; MONOCYTE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING; WOMEN'S HEALTH;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; CHINA; FEMALE; GELSOLIN; GENE EXPRESSION PROFILING; GLUTATHIONE PEROXIDASE; HUMANS; MONOCYTES; OSTEOPOROSIS; PREMENOPAUSE; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN DISULFIDE-ISOMERASES; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS;

EID: 55749088930     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700480     Document Type: Article

References (65)

1. Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K. et al., Risk factors for hip fracture in white women. Study of osteoporotic fractures research group. N. Engl. J. Med. 1995, 332, 767-773.
2. Melton, L. J., III., How many women have osteoporosis now? J. Bone Miner. Res. 1995, 10, 175-177.
3. Deng, H. W., Mahaney, M. C., Williams, J. T., Li, J. et al., Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet. Epidemiol. 2002, 22, 12-25.
4. Liu, P. Y., Qin, Y. J., Recker, R. R., Deng, H. W., Evidence for a major gene underlying bone size variation in the Chinese. Am. J. Hum. Biol. 2004, 16, 68-77.
5. Jian, W. X., Long, J. R., Li, M. X., Liu, X. H., Deng, H. W., Genetic determination of variation and covariation of bone mineral density at the hip and spine in a Chinese population. J. Bone Miner. Metab. 2005, 23, 181-185.
6. Liu, Y. J., Shen, H., Xiao, P., Xiong, D. H. et al., Molecular genetic studies of gene identification for osteoporosis: A 2004 update. J. Bone Miner. Res. 2006, 21, 1511-1535.
7. Liu, Y. Z., Dvornyk, V., Lu, Y., Shen, H. et al., A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J. Biol. Chem. 2005, 280, 29011-29016.
8. Nakamura, M., Udagawa, N., Matsuura, S., Mogi, M. et al., Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 2003, 144, 5441-5449.
9. Martin, T. J., Sims, N. A., Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 2005, 11, 76-81.
10. Zambonin, Z. A., Teti, A., Primavera, M. V., Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. J. Cell Sci. 1984, 66, 335-342.
11. Horton, M. A., Spragg, J. H., Bodary, S. C., Helfrich, M. H., Recognition of cryptic sites in human and mouse laminins by rat osteoclasts is mediated by beta 3 and beta 1 integrins. Bone 1994, 15, 639-646.
12. Parfitt, A. M., Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone. J. Cell Biochem. 1994, 55, 273-286.
13. Fujikawa, Y., Quinn, J. M., Sabokbar, A., McGee, J. O., Athanasou, N. A., The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996, 137, 4058-4060.
14. Higuchi, S., Tabata, N., Tajima, M., Ito, M. et al., Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies. J. Bone Miner. Res. 1998, 13, 44-49.
15. Matayoshi, A., Brown, C., DiPersio, J. F., Haug, J. et al., Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells. Proc. Natl. Acad. Sci. USA 1996, 93, 10785-10790.
16. Purton, L. E., Lee, M. Y., Torok-Storb, B., Normal human peripheral blood mononuclear cells mobilized with granulocyte colony-stimulating factor have increased osteoclastogenic potential compared to nonmobilized blood. Blood 1996, 87, 1802-1808.
17. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H. et al., Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA 1990, 87, 7260-7264.
18. Quinn, J. M., Neale, S., Fujikawa, Y., McGee, J. O. et al., Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif. Tissue Int. 1998, 62, 527-531.
19. Nathan, C. F., Secretory products of macrophages. J. Clin. Invest. 1987, 79, 319-326.
20. Cohen-Solal, M. E., Graulet, A. M., Denne, M. A., Gueris, J. et al., Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: Involvement of cytokines. J. Clin. Endocrinol. Metab. 1993, 77, 1648-1653.
21. Pacifici, R., Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 1996, 11, 1043-1051.
22. Cohen-Solal, M. E., Boitte, F., Bernard-Poenaru, O., Denne, M. A. et al., Increased bone resorbing activity of peripheral monocyte culture supernatants in elderly women. J. Clin. Endocrinol. Metab. 1998, 83, 1687-1690.
23. Carrascosa, A., Gussinye, M., Yeste, D., del Rio, L. et al., Bone mass acquisition during infancy, childhood and adolescence. Acta Paediatr. Suppl. 1995, 411, 18-23.
24. Yao, W. J., Wu, C. H., Wang, S. T., Chang, C. J. et al., Differential changes in regional bone mineral density in healthy Chinese: Age-related and sex-dependent. Calcif. Tissue Int. 2001, 68, 330-336.
25. Manolagas, S. C., Jilka, R. L., Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 1995, 332, 305-311.
26. Pacifici, R., Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 1996, 11, 1043-1051.
27. Deng, H. W., Deng, X. T., Conway, T., Xu, F. H. et al., Determination of bone size of hip, spine, and wrist in human pedigrees by genetic and lifestyle factors. J. Clin. Densitom. 2002, 5, 45-56.
28. Yu, Y., Khan, J., Khanna, C., Helman, L. et al., Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat. Med. 2004, 10, 175-181.
29. van de Wiel, M. A., Significance Analysis of Microarrays using Rank Scores. Kwantitatieve Methoden 2004, 71, 25-37.
30. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
31. Silacci, P., Mazzolai, L., Gauci, C., Stergiopulos, N. et al., Gelsolin superfamily proteins: Key regulators of cellular functions. Cell. Mol. Life Sci. 2004, 61, 2614-2623.
32. Stossel, T. P., Hartwig, J. H., Yin, H. L., Southwick, F. S., Zaner, K. S., The motor of leukocytes. Fed. Proc. 1984, 43, 2760-2763.
33. Perez Castrillon, J. L., Garcia Palomo, J. D., Perez Arellano, J. L., Jimenez, L. A., Leukocyte chemotaxis. Allergol. Immunopathol. (Madr.) 1988, 16, 279-283.
34. Chaponnier, C., Kocher, O., Gabbiani, G., Modulation of gelsolin content in rat aortic smooth muscle cells during development, experimental intimal thickening and culture. An immunohistochemical and biochemical study. Eur. J. Biochem. 1990, 190, 559-565.
35. Cunningham, C. C., Stossel, T. P., Kwiatkowiski, D. J., Enhanced motility in NIH3T3 fibroblasts that overexpress gelsolin. Science 1991, 251, 1233-1236.
36. Arora, P. D., McCulloch, C. A., Dependence of fibroblast migration on actin severing activity of gelsolin. J. Biol. Chem. 1996, 271, 20516-20523.
37. Kwiatkowski, D. J., Functions of gelsolin: Motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 1999, 11, 103-108.
38. Chellaiah, M., Kizer, N., Silva, M., Alvarez, U. et al., Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J. Cell Biol. 2000, 148, 665-678.
39. Akisaka, T., Yoshida, H., Inoue, S., Shimizu, K., Organization of cytoskeletal F-actin, G-actin, and gelsolin in the adhesion structures in cultured osteoclast. J. Bone Miner. Res. 2001, 16, 1248-1255.
40. Chellaiah, M. A., Regulation of actin ring formation by rho GTPases in osteoclasts. J. Biol. Chem. 2005, 280, 32930-32943.
41. Duong, L. T., Lakkakorpi, P., Nakamura, I., Rodan, G. A., Integrins and signaling in osteoclast function. Matrix Biol. 2000, 19, 97-105.
42. Chellaiah, M. A., Biswas, R. S., Yuen, D., Alvarez, U. M., Hruska, K. A., Phosphatidylinositol 3,4,5-trisphosphate directs association of Src homology 2-containing signaling proteins with gelsolin. J. Biol. Chem. 2001, 276, 47434-47444.
43. Wang, Q., Xie, Y., Du, Q. S., Wu, X. J. et al., Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J. Cell Biol. 2003, 160, 565-575.
44. Parfitt, A. M., Osteoclast precursors as leukocytes: Importance of the area code. Bone 1998, 23, 491-494.
45. Jevon, M., Hirayama, T., Brown, M. A., Wass, J. A. et al., Osteoclast formation from circulating precursors in osteoporosis. Scand. J. Rheumatol. 2003, 32, 95-100.
46. Dougherty, G. W., Chopp, T., Qi, S. M., Cutler, M. L., The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. Exp. Cell Res. 2005, 306, 168-179.
47. Masuelli, L., Ettenberg, S., Vasaturo, F., Vestergaard-Sykes, K., Cutler, M. L., The ras suppressor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression. Cell Growth Differ. 1999, 10, 555-564.
48. Lee, N. K., Choi, Y. G., Baik, J. Y., Han, S. Y. et al., A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106, 852-859.
49. Kim, H. J., Chang, E. J., Kim, H. M., Lee, S. B. et al., Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radical Biol. Med. 2006, 40, 1483-1493.
50. Steinbeck, M. J., Kim, J. K., Trudeau, M. J., Hauschka, P. V., Karnovsky, M. J., Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells. J. Cell Physiol. 1998, 176, 574-587.
51. Bai, X. C., Lu, D., Liu, A. L., Zhang, Z. M. et al., Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J. Biol. Chem. 2005, 280, 17497-17506.
52. Fraser, J. H., Helfrich, M. H., Wallace, H. M., Ralston, S. H., Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae. Bone 1996, 19, 223-226.
53. Lean, J. M., Jagger, C. J., Kirstein, B., Fuller, K., Chambers, T. J., Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 2005, 146, 728-735.
54. Ozgocmen, S., Kaya, H., Fadillioglu, E., Aydogan, R., Yilmaz, Z., Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol. Cell. Biochem. 2007, 295, 45-52.
55. Helaakoski, T., Annunen, P., Vuori, K., MacNeil, I. A. et al., Cloning, baculovirus expression, and characterization of a second mouse prolyl 4-hydroxylase alpha-subunit isoform: Formation of an alpha 2 beta 2 tetramer with the protein disulfide-isomerase/beta subunit. Proc. Natl. Acad. Sci. USA 1995, 92, 4427-4431.
56. Chessler, S. D., Byers, P. H., Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. J. Biol. Chem. 1992, 267, 7751-7757.
57. Walmsley, A. R., Batten, M. R., Lad, U., Bulleid, N. J., Intracellular retention of procollagen within the endoplasmic reticulum is mediated by prolyl 4-hydroxylase. J. Biol. Chem. 1999, 274, 14884-14892.
58. Tian, R., Li, S. J., Wang, D. L., Zhao, Z. et al., The acidic C-terminal domain stabilizes the chaperone function of protein disulfide isomerase. J. Biol. Chem. 2004, 279, 48830-48835.
59. Zhao, T. J., Ou, W. B., Xie, Q., Liu, Y. et al., Catalysis of creatine kinase refolding by protein disulfide isomerase involves disulfide cross-link and dimer to tetramer switch. J. Biol. Chem. 2005, 280, 13470-13476.
60. Wetterau, J. R., Combs, K. A., McLean, L. R., Spinner, S. N., Aggerbeck, L. P., Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry 1991, 30, 9728-9735.
61. Sliskovic, I., Raturi, A., Mutus, B., Characterization of the S-denitrosation activity of protein disulfide isomerase. J. Biol. Chem. 2005, 280, 8733-8741.
62. Mezghrani, A., Courageot, J., Mani, J. C., Pugniere, M. et al., Protein-disulfide isomerase (PDI) in FRTL5 cells. pH-dependent thyroglobulin/PDI interactions determine a novel PDI function in the post-endoplasmic reticulum of thyrocytes. J. Biol. Chem. 2000, 275, 1920-1929.
63. Ko, H. S., Uehara, T., Nomura, Y., Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J. Biol. Chem. 2002, 277, 35386-35392.
64. Zhang, S. D., Gant, T. W., Effect of pooling samples on the efficiency of comparative studies using microarrays. Bioinformatics 2005, 21, 4378-4383.
65. Peng, X., Wood, C. L., Blalock, E. M., Chen, K. C. et al., Statistical implications of pooling RNA samples for microarray experiments. BMC. Bioinformatics 2003, 4, 26.